SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-024277
Filing Date
2021-12-01
Accepted
2021-12-01 07:00:49
Documents
12
Period of Report
2021-11-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aveo-20211129.htm   iXBRL 8-K 41093
  Complete submission text file 0001628280-21-024277.txt   174556

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aveo-20211129.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aveo-20211129_lab.xml EX-101.LAB 22875
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aveo-20211129_pre.xml EX-101.PRE 11997
5 EXTRACTED XBRL INSTANCE DOCUMENT aveo-20211129_htm.xml XML 10768
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 211461332
SIC: 2834 Pharmaceutical Preparations